跳至主要内容
临床试验/JPRN-jRCT1051220045
JPRN-jRCT1051220045招募中3 期

A randomized clinical trial of hydromorphone and fentanyl in continuous subcutaneous titration for severe cancer pain - RCT of hydromorphone and fentanyl in continuous subcutaneous titration

Kajiyama Toru0 个研究点目标入组 100 人开始时间: 2022年6月10日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients with severe cancer pain (numerial rating scale 7-10) who desired continuous subcutaneous titration with opioid analgesics.

排除标准

  • Impaired consciousness, delirium, cognitive impairment, renal impairment, hepatic impairment, poor general condition assessment, gastrointestinal transit disorder, patients under 20 years of age, drug allergy to the study drug, and patients who did not consent to participate in the study.

研究者

发起方
Kajiyama Toru

相似试验